Adage Capital Partners Gp, L.L.C. Cerevel Therapeutics Holdings, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$38.96 - $42.75 $1.06 Million - $1.16 Million	27,131 Added 4.66%	609,765 $24.9 Million
Q1 2024 May 15, 2024	SELL	$40.88 - $43.27 $1.5 Million - $1.58 Million	-36,572 Reduced 5.91%	582,634 $24.6 Million
Q4 2023 Feb 14, 2024	SELL	$20.27 - $42.44 $18 Million - $37.6 Million	-886,770 Reduced 58.88%	619,206 $26.3 Million
Q3 2023 Nov 14, 2023	BUY	$20.26 - $31.91 $15.3 Million - $24.1 Million	755,976 Added 100.8%	1,505,976 $32.9 Million
Q2 2023 Aug 14, 2023	BUY	$23.9 - $35.38 $8.4 Million - $12.4 Million	351,480 Added 88.2%	750,000 $23.8 Million
Q3 2022 Nov 14, 2022	BUY	$25.5 - $41.42 $2 Million - $3.25 Million	78,520 Added 24.54%	398,520 $11.3 Million
Q2 2022 Aug 15, 2022	SELL	$20.62 - $37.15 $1.65 Million - $2.97 Million	-80,000 Reduced 20.0%	320,000 $8.46 Million
Q1 2022 May 16, 2022	BUY	$23.5 - $35.38 $2.12 Million - $3.18 Million	90,000 Added 29.03%	400,000 $14 Million
Q4 2021 Feb 14, 2022	BUY	$29.21 - $44.64 $1.75 Million - $2.68 Million	60,000 Added 24.0%	310,000 $10.1 Million
Q3 2021 Nov 15, 2021	SELL	$21.26 - $38.85 $5.32 Million - $9.71 Million	-250,000 Reduced 50.0%	250,000 $7.38 Million
Q2 2021 Aug 16, 2021	SELL	$12.56 - $29.69 $1.26 Million - $2.97 Million	-100,000 Reduced 16.67%	500,000 $12.8 Million
Q4 2020 Feb 16, 2021	BUY	$9.82 - $18.27 $5.89 Million - $11 Million	600,000 New	600,000 $9.95 Million

5.01M

3.3K

Ticker CERE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 155,752,000
Description
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.